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Methods: Twenty-four MRSA and 24 MSSA strains from around 
the world were examined. All the clinical strains had a unique PFGE 
profile and were susceptible to CIP (MIC 0.2-0.3 mg/L). NCTC 
6571, 10442 and isogenic strains BB270 (mecA+) and BB255 (mecA- 
) were also studied. 
Results: The MICs of TRV and MOX for the clinical isolates 
were 10-20-fold lower than that of CIP (M1C.m: TRV 0.025 mg/L, 
MOX 0.05 mg/L). CIP-resistant S. anreus emerged after two steps. 
First-step mutants (FSM) appeared at 4XMIC of the parent strain at 
a frequency of 2.8-3.9X 10.’. Second-step mutants (SSM) showed a 
further increase in MIC (4 mg/L) at a frequency of 1.3X10-”. 
However, with TRV and MOX the FSM appeared at a frequency of 
2-7X10.’ and the mutation rate for acquisition of the SSM was 
10-11. Also, the rates of mutation to resistance did not depend on 
whether the parent strain was methicillin resistant. When the CIP- 
resistant SSM (MIC 4 mg/L) were tested against TRV and MOX, a 
slight increase of the TRV and MOX MICs was observed. 
Conclusions: This study is the first to use a large collection of 
fully quinolone-sensitive S. anrens strains and shows that in vitro 
selection of resistance to TRV and MOX results in a level of resis- 
tance which is still below the therapeutic levels of these drugs. It is 
thus unlikely that they will select resistance in fully quinolone- 
susceptible S. anreus when used clinically. 
Vancomycin-resistant enterococci 
m1 BBL crystal kits identify vancomycin-resistant 
Enterococcus faecium more accurately than 
API Strep systems 
J.M.T. Hamilton-Miller, S. Shah. Royal Free and University Collqe 
Medical School, London, UK 
Objectives: To compare BBL Crystal Rapid Gram Positive (RGP) 
and Gram Positive (GP) kits with API Rapid ID 32 Strep (API132) 
and 20 Strep (APIl20) for identification of vancomycin-resistant E.  
fuerium (VREf). 
Methods: Twenty-eight phenotypically different VREf clinical 
isolates identified by a reference laboratory were tested with the four 
kits. 
Results: API132 was correct for two strains (7%), misidentified 
11 (eight as E. casseliflavus (Ec)), was unhelpful for 13 (‘to genus’ or 
‘doubtful’, highest probability: E.  gallinamm 8, EE 3, Ec: 2), and 
‘unacceptable’ for two. API120 was correct for 16 strains (57%), 
misidentified 11 (10 as Ec) and was unhelpful for one. RG and GP 
kits correctly identified, respectively, 27 (96%) and 26 (93%) strains. 
Conclusions: BBL crystal systems were more reliable than the 
API kits for identifylng VREf. 
[Wl Detection of vancomycin resistance in 
enterococci with the Phoenix System 
J. Reuben, J. Hong, V. Towns, M. Votta, B. Rosenberger. Becton 
Dickinson Microbiology Systems, Sparks, M D ,  USA 
Objectives: To comparatively evaluate the prototype Phoenix 
System (BD Microbiology Systems), an automated ID/AST system 
under development, with the standard broth microdilution (SBM) 
procedure and vancomycin screen agar (VSA) in determining mini- 
mum inhibitory concentrations (MIC) of vancomycin. 
Methods: Frozen stock cultures of 175 enterococci (63 E.faecalis, 
69 E. jiecium and 43 Enterococrnr spp.) were tested. All strains were 
tested in parallel on the same day with a single standardized inocu- 
lum. VSA was tested per manufacturer’s recommendations. SBM was 
performed using PASCO (BD Microbiology Systems) microdilution 
panels. 
Results: The essential accord (EA) between Phoenix and SBM 
for all isolates was 96.6%, with three (1.7%) minor errors. There were 
no major or very major errors. All minor errors occurred with VanB 
phenotypes of E.faecalis. The mean time to results with Phoenix was 
6.5 h (4-15 h). VSA was positive for 15 VanC isolates (E. cassel@avus, 
E. pllinarum, E.Javescens), nine of which tested susceptible by SBM, 
and were excluded from VSA analysis. Results from SBM and 
Phoenix were compared to those from VSA, excluding the VanC 
isolates: 
Broth nlicrodilution (%) Phoenix (%) 
Sensitivity 99.8 99.8 
Specificity 100 97.3 
PPV 100 97.7 
NPV 98.7 98.6 
Conclusions: The Phoenix System is an accurate and rapid alter- 
native to overnight broth microdilution methods for the detection of 
vancomycin resistance in enterococci. The Phoenix System provides 
reliable vancomycin MIC results with a high level of concordance 
with SBM and VSA for the detection of VA resistance in VanA and 
VanB phenotypes. 
Molecular epidemiology of vancomycin- 
resistant Enterococcus faecium isolates from a 
hospital in Gdansk 
M. Kawalec’, K. Szczypa’, W. Hryniewicz’.’. ’Sera and I/accines 
Central Research Laboratory, ZNational REference Centerfor Antibioticr 
Susceptibility Tes t iq ,  Warsaw, Poland 
Objectives: To epidemiologically characterize 15 vancomycin-resis- 
tant E .  faecinm strains isolated in the Children’s Hematology Hospital 
in Gdansk in 1997/98 and sent for further studies to the National 
Reference Center for Antibiotic Susceptibility Testing. 
Methods: The strains were isolated from blood, urine, stool and 
environmental samples. MICs of nine antimicrobial agents were 
determined by the agar dilution method, RAPD patterns were 
obtained with AP7 and AP4 PCR primers, and plasmids were 
isolated and digested with EoRI  and Hind111 restriction endonucle- 
ases. PFGE analysis was performed for strains that were identical 
according to RAPD patterns. 
Results: Fourteen of the isolates were characterized as HLAR 
multidrug-resistant enterococci. All strains exhibited high-level resis- 
tance to vancomycin and teicoplanin, indicating the VanA pheno- 
type, which was then confirmed by PCR. The isolates represented 
three different types accordmg to RAPD and PFGE patterns, one of 
which was represented by 10 isolates (of at least three different 
subtypes). REAP (restriction endonuclease analysis of plasmids) 
showed that only five strains exhibited the same type of pattern (two 
subtypes) and all strains have one common bend. 
Conclusions: This suggested both spread of vanA genes among 
different strains and clonal spread of one resistant strain. 
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In vivo transfer of the vanA gene cluster in the 
intestinal tract of germfree animals 
K.H. Ilahl', T.P. Rokenes', T. Midtvedt2, @. Olsvik',3, A. 
Sundsfjord' .'. 'Deparfment gf Medical Mi~rohiolo~qx Urriversity .f 
Tronzsc~, Norway; LLnboratory .f Medical Microbial Ecolo<ey, Karoiinsku 
Znstitirtet, Stockholm , Sweden; -'Depautntetit gf.Wicrobio/ocqx Uniucrsity 
Hospital gf Eon-1x0, Nc1tway 
Molecular epidemiologic studies have revealed that horizoiital 
spread of resistance genes contributes to the spread of VanA-type 
vancomycin-resistant enterococci (VRE). The aim of  this study was 
to examine the potential contribution of in vivo transformatioii and 
conjugation to the spread of the vunA resistance determinant, 
T n  1546. Conjugation experiments were performed in gnotobiotic 
mice with a vanconiycin-sensitive wild-type Enterococcrts,~ecium strain 
ac recipient. We used one human and three animal VKE strains with 
intact Ti11546 as donors. Bacteria were isolated from the colon of 
sacrificed mice 3 days after colonization with donor strains. In the 
transformdtion experiments, gnotobiotic rats were colonized with 
the same recipient strain and fed 1 mg  of ssDNA or  dsDNA extracted 
from a VRE isolate with intact Tn1546. Transconjugants were 
detected with both human and animal E. faeciutn strains as donors. 
Transfer frequencies of Tn 1546 were 2X 10.' to 2 X lo-' of transcori- 
jugants per donor cell. Transconjugants were verified by specific 
PCRc and similarity in PFGE pattern between transconjugants and 
the recipient strain. We were not able to detect vanconiycin-resistant 
transformants either by direct plating o n  selective media or  by plat- 
ing afier enrichment in selective or  non-selective broth. Our  studies 
document in vivo transfer of Tn1546 between bacteria in the 
mammalian intestinal tract. Both human and animal VRE are able to 
transfer their Ti11546 to a sensitive wild-type E. faeeium strain. The 
negative transformation studies suggest that human VRE may acquire 
their glycopeptide resistance determinants from animal strains by 
conjugation during transient intestinal colonization rather than by 
uptake of free D N A  from food. 
m) Emergence of vancomycin-resistant 
enterococci at a university hospital in Taiwan 
with an emphasis on the persistence of 
multispecies and multiclones of the isolates in 
hospitalized patients 
PR, Hsueh, L.J. Teng, S.W. Ho, K.T. Luh. &Mona/ Taiumi 
G'~tiucrsity Hmpital, 7btpei, Ziwaiz 
Objectives: To deterniine the epidemiology of vanconiycin-resis- 
tant enterococci (VRE) in a university hospital 
Methods: Twenty-five isolates of VRE were recovered from 12 
patients at N T U H  (1996-98). These isolates were characterized by 
their typical biochemical reactions, cellular fatty acid profiles, and the 
presence of van genes. Antibiotypes obtained with the Etest and 
random amplified polyniorphic DNA (RAPD) patterns of these 
isolates were used to determine the clonality 
Results: One patient with perianal abscess had 12 isolates o fVRE 
(four isolates of E. j&ca/is, seven of E. faetiitni, and one of E.  
cusrel~flaui~s) recovered from perianal lesions. Among three patients 
who were hospitalized in the same room, one had a community- 
acquired cellulitis over the left leg caused by €. faecalis, and the other 
two patients both had anal colonization with two isolates of E..faecalis; 
the other eight patientc had one E..faecnlis isolate each from various 
clinical specimens. All isolates possessed the imA resistance pheno- 
type and uanA genes. Multispecies of VRE (E.faccalis, E.  .faeciuin and 
E. cassei!flavirs) and multiple clones of E.  faecium could colonize 
and/or infect hospitalized patients. In addition, the same clones of 
VRE could persist long term in the lower gastrointestinal tract. 
Ilifferent antibiotypes and RAPD patterns of the isolates form differ- 
ent patients excluded the possibility of nosoconiial spread in the 
hospital. 
Conclusions: The result extends our knowledge of the coexis- 
tence and persistence of multiple speciec and niultiple cloiicc of VKE 
in hospitalized patients. 
/p1361 Vancomycin-resistant enteroccci (VRE) 
prevalence in Europe 
M.A. Schouten, J.A.A. Hoogkaniy-Korrtanjr, W.A.G. Kraak. 
C.J.M. Uartels, H.J.G.R. Roelofs-Willemse, A. Voss. L)cp,artriirwt qf 
Medical Microhiolq~fi linivcwity Horpitul St Radboird, .r;t.jrnqeu, T/ic 
A\'cther/ands 
Objectives: To determine VRE prevalence in European countries. 
Methods: During the first quarter of 1997, colleagucr i n  40 
hospitals (27 countries) collected 4208 clinical enterococcal strain\ 
from different patients (inaximum 100 strains per ccntcr) togcthcr 
with clinical data. The species identification and susceptibility te\t- 
ing by inicrobroth dilution (NCCLS) was performed in our Iabora- 
tory. V a i ~  genes were determined using PCR techriiques. 
Results: C'nriA VRE: 17 strains. PrevJlence (X): Belgium I ;  Czech 
Republic I ;  France 0.3;  Germany 0.5; Israel 2; Italy I ;  Slovak 
Republic I; UK 2.9. VanB VRE: 4 strains. Prevalence: Sweden i1.3; 
Finland I; Slovenia 2. VanA and VanB VKE were identified: f:. 
faecirrm 90%; E. faecalir 10%. Sites of isolation were: urogenital tract 
(20'%), skin (20%), digestive tract (20%), blood ( 1  i)'X,), respiratory 
tract (S%), other (25%). Eighty per cent were clinical: curgrry ( 1  5%), 
pediatric ICU (1 O%), internal medicine (10%). l 4 ~ C  [,'RE: 6 X  
strains. Prevalence: Austria 0.7; Bulgaria 5; Croatia 1 . I ;  Czech 
Republic 3; Denmark 0.4; France 5.2; Germany 2.4; Hungary I ;  
Israel 0.5; Italy 0.7; Latvia 11.9; Lithuania 4; The Netherlands 0.4; 
Norway I; Poland 0.5; Russia 1.5; Slovak Ilepubhc 3.2; Spain 0.4; 
Turkey 11 .h; UK 1.5. Identification: E.  caassa/!flavirs (66%). E .  p//i- 
M ~ I M J  (34%). Isolation site: digestive tract (56%). iirogcnital tract 
(21'%), skin (lO%), blood (h%), other (7%). Ninety-three per cent 
were from hospitalized patients, mostly from pediatrics (32%1). 
Conclusions: European VRE prevalence in clinical isolates IS ctill 
low; most of the encountered strains have the v m C  genotype. 
[p1371 Vancomycin-resistant enterococci in Austria 
D. Orth',  A. Mellniann', E Allerberger', M.1? Dierich', I .  Khre', 
W. Witte'. 'Iustitirt j t r  Hy$em, h s b r u r k ,  Austria; 'Rohwt K d t  
ltisritut, Wern<qerode, Germany 
Objectives: To study the prevalence of glycopeptide-resist.tnt entc- 
rococci from different ecological sources in Austria. 
Methods: Stool specimens from patient\ front intemivc carc units, 
general wards and outpatient clinics (approxiinately SO per group) at 
the university hospital Innsbruck and from approximately 500 healthy 
non-hospitalized human volunteers were cultured onto Eiitcro- 
coccosel Agar (Becton Dickinson, Cockeysville, USA) supplenicnted 
with 50 mg/L vanconiycin (EL Lilly, Gieqsen, Germany) and 4 mg/L 
cefodizime (Usiphar Roussel Uclaf, Conipiegne, France) and incu- 
bated for 48 h in ambient atmosphere. Api 20 STREP (BioMerieux, 
Marcy Etoile, France) was used for ide~irification. Fecal spcciiiiei~i 
from 105 Tyrolean milk cows were proc 
Results: O f  hospitalized patients, IO'XI harbored vancornycin- 
resistant enterococci (mainly E.faeciurn) as did 3.5% of healthy human 
Tyroleans (mainly E. avirrm and E.jhcciirm). Ten per cent of the fecJ 
specimens from cows had resistant strains. 
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Conclusions: The results of our study underline that oral 
vancomycin administration to hospitalized humans is a primary cause 
of VRE in Austria. In Austria, approximately 66 kg of vancomycin, 
20% of it given orally, are administered to patients per year. From 1 
April 1997, the use of avoparcin as a feed supplement has been 
prohibited by the European Commission. Nevertheless, E. fnecium 
resistant to glycopeptides was also found in healthy human volunteers 
and healthy Tyrolean cows. 
Ip1381 Isolation and detection of vancomycin- 
resistant enterococci in a district general 
hospital 
M. Kerawala, A.M. Al-Shaqqa, F! Lee, Y Drabu. Nortk Middlesex 
Hospital NHS Trust, London, UK 
Objectives: To look at fecal carriage of vancomycin-resistant ente- 
rococci (VRE) at a district general hospital using a novel screening 
medurn and BBL crystal Gram Positive Identification System 
(Becton Dickinson). 
Methods: Two hundred and twenty-seven routine stool samples 
from inpatients and the community were plated onto: Staph/Strep 
agar-SSA (Columbia blood agar with staph/strep Prolab supplement); 
modified aesculin agar-MAA (bile aesculin agar and LabM supple- 
ment incorporating nalidixic acid, 20 mg/L, and vancomycin, 5 
mg/L). Initial susceptibilities to vancomycin (Va) 4 mg/L and 
teicoplanin (Tc) 8 mg/L were carried out by the breakpoint method 
followed by agar dilutions. Further sensitivities to ampicillin (Amp) 
8 mg/L, erythromycin (E) 2 mg/L, tetracycline (T) 2 mg/L and 
high-level genramicin (HLG) 1000 mg/L were also determined. AU 
VRE strains were identified to species level by BBL crystal. 
Results: O f  157 enterococci recovered, 13 VRE were isolated 
from MAA, six from MAA and SSA, and one from SSA only. VRE 
isolates were identified as E.  casrel~auus/gallinarum= 12, E. auium= 1, 
E. raginosur=2 and E.  solitarius=l; all were intermediately Va resis- 
tant (MIC=8-16 mg/L). One E.faecittm strain was intermediately Va 
resistant, while three strains (E. faecium=2, E .  fnecalis=l) had Va 
MIC=128 mg/L and Tc MIC=1&32 mg/L. Other antibiotic resis- 
tances encountered in 20 VRE strains were Anip=2, E=8, T=6,  
HLG=1 and Tc=3. 
Conclusions: Although VRE infections have not been observed 
in our hospital, fecal carriage rate in this study was found to be 8%. 
M11 is a suitable and cost-effective medium for screening VRE carri- 
ers. BBL crystal identified all VRE; E.  casselijlpauus and E. pllinarum 
were not well differentiated. 
v1 Detection of glycopeptide-resistant enterococci 
M.A. Lee, S.Y. Lee, J.H. Park, H.S. Park, E.S. Kang, K.S. Hong, 
W.S. Chung. Department of Clinical Pathology, Etvka Womans 
University, College o f  Medicine, Seoul, Korea 
Enterococci are a leading cause of nosocomial infections, and the 
emergence of resistant strains to glycopeptides in enterococci (GRE) 
is an increasingly serious problem throughout the world. Automated 
methods and disk diffiision tests have difficulties in detecting some 
strains of vancomycin-resistant enterococci (VRE), especially those 
having vanC genotypes. A few studies have been done assessing the 
ability of antimicrobial susceptibility methods to detect teicoplanin 
resistance in enterococci. We evaluated the abilities of two commer- 
cial kits (Vitek GPS-IZ, Etest), the disk diffusion test and the stan- 
dard agar dilution test to detect glycopeptide resistance in 34 strains 
of uanA VRE (MICs 256-2048 mg/L) and 15 strains of uanCI/CZ 
VRE (MICs 8-16 mg/L). In detecting vancomycin resistance, no 
very major or major errors were seen, and minor error rates were 
observed with disk diffusion (25%), Vitek GPS-IZ (20%) and Etest 
(10%). Overall sensitivities of all three methods in detecting uauA 
VRE were 97-loo%, but sensitivities of disk diffusion, Etest and 
Vitek GPS-IZ in detecting vanC VRE were 20%. 87% and 87%. 
respectively. In detecting teicoplanin resistance, the very major error 
rate was high in Vitek GPS-IZ (47%), but no very major or major 
errors were seen in disk diffusion and Etest; minor error rates of 2% 
and 6% were seen in Vitek GPS-I2 and Etest, respectively. In conclu- 
sion, vanA VRE are detected by all three methods, but commercial 
methods and the disk diffusion method continued to demonstrate 
problems in detecting low-level vancomycin resistance, and Vitek 
GPS-IZ has difficulty in detecting teicoplanin resistance in entero- 
cocci. 
[p1401 Risk factors for VRE infection and colonization 
M.A. Lee, J.H. Park, W.S. Chung. Department of Clinical Pafkology, 
Ewka Womans University, College $Medicine, Seoul, Korea 
The emergence of vancomycin-resistant enterococci (VRE) is an 
increasingly serious problem throughout the world and is likely to 
increase in Korea. However, a few epidemiologic studies and risk 
factors of VRE infection have been reported in Korea. We analyzed 
18 patients with VRE infection and 21 patients with VRE fecal colo- 
nization in Ewha Womans University Hospital h m  December 1996 
to August 1998. To assess the risk factors for VRE infection and colo- 
nization, we reviewed the medical records of patients with VRE 
(n=39) or vancomycin-sensitive enterococci (VSE, n=60) and 
performed case-control studies. The incidence of VRE infection was 
7.9% of all enterococcal isolates, and the incidence of VRE colo- 
nization from surveillance cultures increased from 0.1% to 1.6% from 
1997 to 1998. Genotypes of VRE isolates showed 33 strains of uanA, 
four strains of vanCl and two strains of uanC2. Compared with 
patients with VSE, patients with VRE had significantly longer hospi- 
tal stay, had more frequent stays in the ICU and oncology ward, had 
more frequent invasive procedures such as central lines, urinary 
catheters, nasogastric tubes and ventilators, showed impaired renal 
function more kequently, and were more likely to have received 
vancomycin, aztreonam or aminoglycoside therapy. Compared with 
the patients colonized with VRE, the patients infected with VRE 
had significantly less frequent stays in the ICU and impaired renal 
function less frequently. In conclusion, patients with longer hospital 
stay, underlying diseases, previous antibiotic therapy or invasive 
procedures were at risk for VRE infection and colonization. To 
prevent VRE infection and colonization, appropriate antibiotic ther- 
apy according to the guidelines and cautious handling of medical 
devices may be necessary. 
[m] Comparison of human and animal vanA 
Enterococcus faecium in Belgium 
H. Goossens, P. Descheemaeker, S. Chapelle, M. Leven, €? 
Vandanune, L.A. Devriese. Uniuersify Antwerp, Medicine, Antwerp, 
Belgium 
The objective of the study was to compare the susceptibility patterns, 
clonality and the Tn1546-like elements of 75 human and 61 animal 
strains of uanA-positive E. faecium strains collected in Belgium since 
1994. MICs were determined by agar dilution according to the 
NCCLS. Clonality was explored by PFGE using the restriction 
enzyme SmaI. Complete transposon amplification was followed by 
RFLP analysis using the restriction enzyme DdeI. The MICSO values 
(in mg/L) for ampicillin (AMP), ciprofloxacin (CIPRO), gentamicin 
A b s t r a c t s  123  
(GEN) and streptomycin were respectively 8, 2,  8 and 512 for the 
huinan isolates, and 8, 2, 8 and 512 for the animal isolates; the 
values were 64, 8, 16 and 512 for the human isolates and 16, 4, 16 
and 512 for the animal isolates. Clearly, the susceptibility patterns are 
comparable for the human and animal strains, and, in contrast to the 
USA, the huiiian isolates remain susceptible to AMP, CIPRO and 
GEN. 
Transposon typing revealed nine different types: type 1 and type 2 
accounted for 19.9% and 60.3% of the strains, respectively. No host 
specificity was detected. The Smal PFGE patterns showed a very high 
genetic heterogeneity. Indistinguishable isolates were anecdotally 
present in both aniinal and human hosts. Strains characterized by the 
same PFGE pattern were found to harbor different transposon types. 
I n  conclusion, we found phenotypic and genotypic similarity 
among uanA E. jieciitm strains of human and animal origin. 
Phenotypically, these GKE appear to be different from G R E  isolated 
among patients in the USA. 
[p1421 Vancomycin-resistant fnterococcus faeciurn 
(VREF) persist longer than vancornycin- 
susceptible fnterococcus faeciurn (VSEF) in 
healthy adults 
J. Fitzncr, K. W w t ,  0. Sahawala, H. Khdcn. lnstifutc (?fHy@nc, 
Free University .f Berliir, Berlin, Germany 
Objectives: To study the persistence of Eiiterococctrs.faeciuni strains in 
healthy adults and to determine if there is a diffei-ence between the 
persistence of VKEF and VSEF. 
Materials and methods: Between August 1996 and February 
1997 we collected nionthly ctool sainples of 86 healthy adults. U p  to 
five cnterococcal colonies were frozen each month for further eval- 
uation. For this study we selected the enterococci of 30 persons. All 
enterococci showing the typical growth and sugar reactions of E.  
fbeciurri were fiuther identified with species-specific PCR, using the 
DDL primer set. All E. jxcir tm strains were typed with an RAPD- 
PCR,  using the M13 primer. A correspondence of 90% of the niole- 
cular pattern was defined as identical, determined with the gel 
coinpare prograin. Vanconiycin resistance was defined as a ininiinal 
inhibitory concentration of 32 nig/L. 
Results: Two hundred and four enterococci met the criteria of E.  
$c~;urii, resembling 96 different strains. The average number of strains 
per person was 3.1 during the study period. Twenty-two of the strains 
were vancoinycin resistant. The  average persistence of a VSEF strain 
was 1.1 month, and that of a vancomycin-resistant strain was 2 
months. This difference is statistically significant. 
Conclusions: A VREF strain persists longer in a healthy adult 
than a VSEF strain. The reasons for these differences have still to be 
determined. 
Ip143) Repeated prevalence study to detect fecal 
carriage of vancomycin-resistant enterococci in 
hospitalized patients 
D.H. Forster, A. Becker, E. Kniehl, Stadtisches Kliwikirni, ZLM?; 
Abt. , f i r  h'&obio/i~~~y, Karkrrrhe, C;errmiiy 
Vdnconiyciii-resistant eriterococci (VRE) have emerged worldwide 
as nococomial pathogens. In Germany, vancomycin-resistant E. 
jieciurri strains were found in up to 12% of  fecal samples from humane 
in the community. However, the prevalence of VRE stool carriage 
in humans seeins to be regionally different in Germany. In our hospi- 
tal (teaching hospital, 1500 beds), VILE have been extremely rarely 
found in clinical speciinens so far. In order to estimate the frequency 
of V l iE  colonization of patients, we studied the frequency of fcc.11 
carriage of VRE in our intensive care unit (ICU) patients in a 
repeated prevalence study Patients on four ICUs were screened on 
thrce different occasions at least 6 weeks apart in a 3-iiionth period. 
Iiectal swabs were taken froin 82 patients and cultured on Entero- 
coccosel agar (Decton Ikkinsoii, Oxford, UK) stippleinented with 
5 mg/L vancoinycin. Esculin-positive colonies were verified with 
standard methods. Vanconiycin and teicoplanni resistance were 
detected by the Etest (AB Biodisk, S o h ,  Sweden). No E..facriirm or 
E .  .ficcalis stram with vanco~nycin resistance or intermedinte 
vanconiycin susceptibility were found. In the rectal swabs of SIX 
patients (7.3%), enterococci species with intriiicic low-level 
vanconiycin resistance were detected (four E. raw/iflovitr, two I : .  
pdlitinrnnz, MIC 6-12 ing/L). Kcpeated screening of ICU patient\ 
with rectal swabs cultured on Enterococcosal agar suppleinented with 
vancomycin is a method that can be easily integrated into a rou tn i~  
microbiology laboratory and that providec inforination concerning 
the prevalence of VILE colonization in  hospitalized patient, of a 
certain community. 
m/ Glycopeptide-resistant enterococci (GRE) in 
hospital food 
M. Delinee, J. Kersbergen, M. Janssens, J. Tollenacre, V. Avcsani 
Ilniui&y (f Lowain, A4;rriilJidqy Unit, Brir.~s~lr, Be!eiuni 
Objectives: To study the prevalence of glycoprptide-resist'int ente- 
rococci (GRE) in food distributed to the patient\ of an 884-bed 
university hospital. 
Methods: Three series of 120 food saniples were investigated: one 
froin several stores in the Drussels area, and the other two from the 
kitchen of the St Luc University Hospital taken at n 3-iiionth i n t ~ r -  
Val. GI1E were detected by using selective bile-esculine broth. 
Susceptibility was determined by Etests, iwrA and inriB gene\ by 
multiplex PCR,  and clonal relatedness by pulsed-field gel elec- 
trophoresis (PFGE). 
Results: GRE were detected in none of the 120 speciinens from 
the stores and in 6/120 (5%) sainples from the first scric\ in the ho\pi- 
tat: four E..facriiirii (two from raw olive ofveai and two from raw youl- 
try) and two E. liirac (one from raw ground veal and one from a 
prepared salad); 2/120 (1.7%) specimens of the last certec contained 
rrsistant E. $ c ~ i u m  (twice in raw veal). All eight <;RE displayed the 
vanA phenotype. All six E. ,faeciuni strains showed different re\triction 
profilec by PFGE, whereas both strains of E.  liirae had a \imilar profile\. 
Conclusions: Eight of 240 (3.3%) food \amples in  the hospitd 
cont~ined GRE: food distributed to patients might thereforc be a 
source ofcontaniination by GRE; raw ved  and poultry were thcs niost 
contaiiniiated products; absence of clonal relatednes aiiiong E .  
j i e h m  suggests a selection pressure in animals rather than cross-con- 
ainination after slaughtering; the similar patternc of both E. liirrrc 
strains suggest the possibility of c ro~s -co i i t a i i i i i i a t~~~~~  in the h0cpit.d 
kitchen. 
Epidemiology of vancomycin-resistant 
Enterococcus faeciurn infections in a 
hematologic unit 
M. Uronk, A. Samet, J. Komariiicka, L. Nauniiuk. Stnti, Clirrical 
Hospifal N o  1 ,  Bactcriolopy, Gdatisk, Polorid 
Objectives: To study the epidennology of vancnmycin~rerictar~t 
E,ilemr~rcus-faecinn~ (VREM) in  a hematologic unit. 
Methods: I>uring a 1-year period (Ileceinber 1906 to October 
1997). 49 VREM were isolated from 29 heni~tologic pat~eilts. 
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Susceptibility to vancomycin, teicoplanin, penicillin, streptomycin 
and gentamicin was determined using three methods: microdhtion, 
disk diffusion and Etest. The production of beta-lactamase was 
assessed with nitrocefin disks. Typing was pedormed by PCR. 
Results: All strains were resistant to vancomycin, teicoplanin, 
penicillin, streptomycin HL and gentamicin HL. The pheno- and 
genotypic analyses of all VREM isolates indicated the presence of the 
uanA genotype. VREM were isolated from blood samples (lo), 
sputum (3). stool (29), urine (3). skin (2), vagina (1) and throat (1). 
Eight patients were infected (positive blood cultures) and 21 were 
colonized (positive stool cultures). 
Conclusions: We describe the first outbreak due to VREM in a 
hematologic unit in Poland. VREM presented a new therapeutic 
problem in hematologic patients, especially after bone marrow trans- 
plantation. However, their true clinical significance in our patients 
was not clear. 
I PI 461 Chloramphenicol treatment for vancomycin- 
resistant Enterococcus faecium (VREF) 
bacteremia 
J.C. Ricaurte, G.S. Turett, J.W. Kislak, Saint Kncents Hospital, 
Infectious Disease, New York, USA 
The incidence of VREF bacteremia has been steadily increasing. 
VREF infections are challenging, since resistance to ampicillin and 
aminoglycosides is usually present as well. Patients with VREF 
bacteremia frequently have significant co-morbidities and a high 
mortality rate. We recently had success in treating sustained VREF 
bacteremias with chloramphenicol. 
Our hospital has a large oncology service. Between January and 
May 1998, six episodes of sustained VREF bacteremia occurred in 
five cancer patients. Mean age was 55 years; three were neutropenic 
at the time of bacteremia. VREF were isolated in pure culture in 
all patients. All isolates were resistant to vancomycin, ampicillin 
and aminoglycosides but were susceptible to chloramphenicol. 
Chloramphenicol dosing ranged from 750 mg to 1 g IV q6h. Four 
of six episodes of VREF bacteremia occurred in patients with chronic 
indwelling central venous catheters (one patient also had a biliary 
stent). These devices were left in place: the only intervention was 
instituting chloramphenicol therapy. 
In four episodes, patients received chloramphenicol for 10-21 
days, and had clinical and microbiological responses. Another patient 
who received 5 days of chloramphenicol had a microbiological 
response but died of his underlying malignancy. The last patient had 
a sustained VREF bacteremia over 3 days and died within 48 h of 
starting chloramphenicol. 
In summary, five of six episodes of VREF bacteremia in severely 
ill cancer patients responded clinically and/or microbiologically to 
chloramphenicol. These data suggest that chloramphenicol may be 
useful in treating infections with this highly resistant organism. 
v1 Vancomycin-resistant enterococci (VRE): a 
point prevalence study of intestinal 
colonization in hospitalized patients 
E. Cercenado, L. Alcala, B. Padilla, F. Garcia-Garrote, L. Tonnes, 
E. Bouza. Hospital General Liniuersitario ‘Gregorio Maranon ’, Madrid, 
Spain 
In our hospital the incidence of VRE from 1988 to 1998 has oscil- 
lated between 0.5% and 0.7%. The routine isolation of VRE in 
microbiology laboratories probably underscores the rate of intestinal 
colonization with VRE. 
Objectives: To investigate the prevalence of fecal carriage ofVRE 
among all patients admitted to our hospital. 
Materials and methods: We carried out a point prevalence 
culture survey in a single day by culturing fecal samples of all hospi- 
talized patients in M-Enterococcus agar media supplemented with 
vancomycin (6 mg/L). Susceptibilities to vancomycin and teicoplanin 
were determined by the microdilution method (NCCLS). 
Results: At the time of the study, the hospital occupation was 
1274 beds, and 844 patients (66%) were allowed to provide a fecal 
sample. Forty of the 844 patients (4.7%) were found to be VRE 
carriers. Thirty-one strains were Enteroroccus faecium, three were 
Enterococcus faecalis, three were Enteroroccur durans, and three were 
Enferococcns casseliJ¶pauus. We obtained 83% VanA (30 (94%) E.faecium, 
three E .  duranr, and one E.faecalis), 5% VanB (two E &ecalis), and 
seven VanC (three E .  rassel&uus). An epidemiologic study revealed 
that although VRE colonization was more frequent among 
vancomycin-treated patients (OR= 1.98) and those at ICUs 
(OR= 1.70). a significant associated risk factor was duration of hospi- 
talization (p< 0.05). 
Conclusions: A low rate of colonization with VRE was detected 
in our institution. N o  association was found between the use of 
vancomycin and the isolation of VRE. 
Immunology, host defences, vaccination I 
Ip1481 Humoral and cellular immune responses of 
mice following oral immunization with cholera 
toxin 
G.I. Vasilieva, V.N. Kozlovsky. Research Institutefor H a p e  Control, 
Rostou-on-Don, Russia 
Objectives: Humoral, cellular and local immune responses follow- 
ing oral immunization of BALB/c mice with cholera toxin (CT) 
were investigated. 
Methods: The study was conducted with use of ELSA and the 
indirect immunofluorescent method. 
Results: Oral administration of C T  provided the certain eleva- 
tion in Peyer’s patches and lamina propria of an amount of B- 
lymphocytes bearing membrane immunoglobulins of various 
isotypes and increase of CT-specific lgA, IgM (especially) and lgG1 
titers in gastrointestinal lavage fluids and fecal extracts. In sera, eleva- 
tion mainly in 1gG1 antibody titers and moderate increases in 
amounts of IgA, IgGz,, IgGzb and IgGi were observed. These find- 
ings testify to the advantages of oral CT administration for induction 
of secretory IgA production. The observable changes in humoral 
immune response were accompanied by elevated secretion of IL-4, 
IL-5 and IL-6 on a background of moderate IL-2 production, indi- 
cating involvement of these three cytokines in B-cell maturation 
processes. Parenteral application of C T  was accompanied by not only 
moderate secretion of IL-2. but also an insignificant increase of IL-6 
production and absence of stimulation of interferon-gamma produc- 
tion. Probably, these findmgs indicate the insufficiency of the growth 
factors for adequate differentiation of not only T-lymphocytes but 
also B-lymphocytes. 
Conclusions: C T  used orally stimulates the creation of rather 
intense local immunity and development of the certain systemic 
response which is not accompanied by significant immunodeficiency 
as with parenteral administration. 
